Insider trade

Jazz Pharmaceuticals (JAZZ): Officer sold ~$1.63M

Samantha Pearce, Officer at Jazz Pharmaceuticals, sold ~$1.63M of Jazz Pharmaceuticals shares.

~$1.63M
Approx. value · 6,907 sh @ $235.41
50K
Holds after · shares reported
Traded
May 28, 2026
Filed
Jun 2, 2026

What stands out in this filing

  • Samantha Pearce's largest sale of JAZZ in their filings since 2022.
  • Samantha Pearce's first sale of JAZZ since Feb 2023.
  • The sale was 12.1% of the shares this insider held before it; the filing reports 50,272 shares afterwards.
  • 6,907 shares at an average of $235.41 each, as reported on the form.
  • No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

The company's last weighty Form 8-K report up to this date: changed a top executive or board member, 3 days earlier (May 25, 2026). The first one after it: reported its results, 67 days later (Aug 3, 2026).

  1. Insider · 1 personInsiders: 3 sales (~$1.1M)
  2. InsiderDirector sold ~$1.22M of JAZZ shares in the open market
  3. Company filing · Form 8-K · ResultsReported its results
  4. Insider · 2 peopleInsiders: 2 sales (~$1.1M)
  5. Company filing · Form 8-K · Executive changeChanged a top executive or board member“On May 25, 2026, Anne O’Riordan, a Class III director whose term expires at the Jazz Pharmaceuticals plc (the “Company”) 2026 annual meeting of shareholders, has informed the board of directors (the “Board”) that she will not stand for re-election.”
  6. Insider · Their largest sale since 2022Officer sold ~$1.63M of JAZZ shares in the open market

What came next

  1. InsiderOfficer sold ~$282K of JAZZ shares in the open market
  2. InsiderDirector sold ~$1.41M of JAZZ shares in the open market
  3. InsiderOfficer sold ~$278K of JAZZ shares in the open market
  4. InsiderDirector sold ~$267K of JAZZ shares in the open market
  5. InsiderDirector sold ~$1.44M of JAZZ shares in the open market
  6. Company filing · Form 8-K · ResultsReported its results
  7. InsiderDirector sold ~$1.52M of JAZZ shares in the open market
  8. Company filing · Form 8-K · Material agreementSigned an important agreement
  9. Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 2 more items)
  10. Insider · 1 personInsiders: 6 sales (~$19.2M)
  11. InsiderDirector sold ~$1.5M of JAZZ shares in the open market
  12. InsiderCEO sold ~$486K of JAZZ shares in the open market
  13. InsiderOfficer sold ~$289K of JAZZ shares in the open market
  14. Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Jazz Pharmaceuticals

For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its JAZZ page.

How this filing works

Explore the data

Common questions

Which Jazz Pharmaceuticals (JAZZ) insider traded, and how much?

Samantha Pearce, Officer at Jazz Pharmaceuticals, sold ~$1.63M of Jazz Pharmaceuticals shares. 6,907 shares at $235.41.

When did it happen, and when was it made public?

Traded: May 28, 2026. Filed: Jun 2, 2026. That is 5 days between the two dates.

What stands out in this filing?

Samantha Pearce's largest sale of JAZZ in their filings since 2022. Samantha Pearce's first sale of JAZZ since Feb 2023. The sale was 12.1% of the shares this insider held before it; the filing reports 50,272 shares afterwards.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Jazz Pharmaceuticals recently?

For Jazz Pharmaceuticals, OQRO holds 25 insider filings (SEC Form 4 or Form 144) dated in the last 90 days. They are listed on the JAZZ page.

Does this mean JAZZ stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Jazz Pharmaceuticals

Everything OQRO holds on this company is on its JAZZ page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data